AG 213
AG 213 Basic information
- Product Name:
- AG 213
- Synonyms:
-
- ALPHA-CYANO-3,4-DIHYDROXYTHIOCINNAMAMIDE
- ALPHA-CYANO-(3,4-DIHYDROXY)THIOCINNAMIDE
- AG 213
- 3,4-DIHYDROXY-ALPHA-CYANOTHIOCINNAMAMIDE
- (E)-2-CYANO-3-(3,4-DIHYDROXYPHENYL)-2-PROPENTHIOAMIDE
- TYRPHOSTIN A47 99+%
- AG 213 (Tyrphostin AG 213)
- ZGHQGWOETPXKLY-XVNBXDOJSA-N
- CAS:
- 122520-86-9
- MF:
- C10H8N2O2S
- MW:
- 220.25
- Product Categories:
-
- Intracellular Signaling
- Protein Kinase
- Mol File:
- 122520-86-9.mol
AG 213 Chemical Properties
- Melting point:
- 213 °C
- Boiling point:
- 474.5±55.0 °C(Predicted)
- Density
- 1.512±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMSO: 50 mg/mL, clear, orange
- form
- Orange solid.
- pka
- 8.82±0.10(Predicted)
MSDS
- Language:English Provider:SigmaAldrich
AG 213 Usage And Synthesis
Description
Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs. Tyrphostins are a class of antiproliferative compounds that act as PTK blockers. PTK inhibitors which preferentially inhibit the epidermal growth factor (EGF) receptor kinase block EGF-
Uses
Tyrphostin 47 is a potent inhibitor of EGFR kinase activity.
Definition
ChEBI: 3-amino-2-[(3-hydroxy-4-oxo-1-cyclohexa-2,5-dienylidene)methyl]-3-mercapto-2-propenenitrile is a member of quinomethanes.
Biological Activity
Epidermal growth factor receptor (EGFR) and platelet-derived growth factor receptor (PDGFR) kinase inhibitor (IC 50 values are 2.4 and 3 μ M respectively). Stimulates microtubule polymerization and promotes neurite outgrowth > 17-fold over basal conditions in vitro . Also weakly inhibits protein kinase C (IC 50 = 60 μ M).
References
[1] romer l h, mclean n, turner c e, et al. tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells[j]. molecular biology of the cell, 1994, 5(3): 349-361.
[2] gazit a, yaish p, gilon c, et al. tyrphostins i: synthesis and biological activity of protein tyrosine kinase inhibitors[j]. journal of medicinal chemistry, 1989, 32(10): 2344-2352.
[3] levitzki a, gazit a. tyrosine kinase inhibition: an approach to drug development[j]. science, 1995, 267(5205): 1782.
[4] herbst r s. review of epidermal growth factor receptor biology[j]. international journal of radiation oncology biology physics, 2004, 59(2): s21-s26.
AG 213Supplier
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 0330-2528181
- sales@vdmbio.com
- Tel
- 16314854226
- info@bocsci.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- +86-29-89586680 +86-15129568250
- 1026@dideu.com
AG 213(122520-86-9)Related Product Information
- AG 18
- TYRPHOSTIN A9
- TYRPHOSTIN A25
- Canertinib
- TYRPHOSTIN A51
- AG 1295
- AG 490
- AG 1478
- NS-398
- BIS-TYRPHOSTIN
- AG 825
- 2-Propenoic acid, 2-cyano-3-(3,4-dihydroxyphenyl)-, (2E)- (9CI)
- TYRPHOSTIN A63
- TYRPHOSTIN A1
- AG 99
- TYRPHOSTIN AG 1288
- AG 213,TYRPHOSTIN AG 213
- (E)-N-(3''-PHENYLPROPYL-ALPHA-CYANO-3'-5'-DIISOPROPYL-4'-HYDROXYCINNAMAMIDE)